For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Some people who have constant pain in their knees have a condition called osteoarthritis. Unlike the temporary pain and inflammation caused in a joint by an overactive immune system response, osteoarthritis is a degenerative joint disease. Viscosupplementation is a procedure in which a thick fluid called hyaluronate is injected into the knee joint. There are no cures for osteoarthritis, so viscosupplementation will not cure osteoarthritis of the knee. However, it is thought that hyaluronate will improve the lubricating properties of the synovial fluid, reduce the pain from osteoarthritis of the knee, improve mobility, and provide a higher and more comfortable level of activity.
The Viscosupplementation for Knee Osteoarthritis market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Viscosupplementation for Knee Osteoarthritis industry, and breaks down according to the type, application, and consumption area of Viscosupplementation for Knee Osteoarthritis. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Viscosupplementation for Knee Osteoarthritis in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Viscosupplementation for Knee Osteoarthritis market covered in Chapter 11:
Ferring
Seikagaku
Bioventus
Sanofi
Lifecore Biomedical
LG Life Sciences
Zimmer
Anika Therapeutics
In Chapter 3, on the basis of types, the Viscosupplementation for Knee Osteoarthritis market from 2018 to 2028 is primarily split into:
Single Injection
Three Injection
Five Injection
In Chapter 4, on the basis of applications, the Viscosupplementation for Knee Osteoarthritis market from 2018 to 2028 covers:
Hospitals
Clinics
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028